• Mashup Score: 0

    March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely transcatheter device-based therapy to address heart failure (HF), has announced that patients treated with the investigational AccuCinch Ventricular Restoration System demonstrated improvement in HF patient outcomes and beneficial changes in the structure of the heart. The 12-month data…

    Tweet Tweets with this article
    • @DAICeditor @AncoraHeart Ancora Heart’s #AccucinchSystem demonstrated significant improvement in quality of life, #cardiac structure and function in #heartfailure patients, according to data presented in a late-breaking clinical science session at #tht23: https://t.co/6qt7FpV7KC

  • Mashup Score: 2

    The CardioNerds are excited to be covering the CRF Technology and Heart Failure Therapeutics (THT) 2023 conference to be held in Boston, March 20-22. In

    Tweet Tweets with this article
    • RT @mydocwire: CardioNerds at THT 2023 https://t.co/Qw5Mu0obHb via @mydocwire @CardioNerds @CardioNerdsJC #THT23

  • Mashup Score: 0

    The CardioNerds are excited to be covering the CRF Technology and Heart Failure Therapeutics (THT) 2023 conference to be held in Boston, March 20-22. In

    Tweet Tweets with this article
    • CardioNerds at THT 2023 https://t.co/Qw5Mu0obHb via @mydocwire @CardioNerds @CardioNerdsJC #THT23

  • Mashup Score: 1

    Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500[email protected]© 2023, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use

    Tweet Tweets with this article
    • Looking forward to what's looking like a great #THT23 with @crfheart next week! Glad to see ATTR #amyloidosis becoming a more and more common topic of discussion on #CardioTwitter and #cardiology circles. https://t.co/Hy1GdL3WTW https://t.co/beOibPgeWK

  • Mashup Score: 2

    Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500[email protected]© 2023, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use

    Tweet Tweets with this article
    • An outstanding meeting of #HF technology, therapeutics, minds, hearts, & friends! #THT23 Check out the program & register. https://t.co/MUdfbMzj9W https://t.co/Sw3OAE6wNh @crfheart https://t.co/BPIylKAed4

  • Mashup Score: 2

    Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500[email protected]© 2023, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use

    Tweet Tweets with this article
    • #THT23 @crfheart is coming up 3/20-22 in Boston And we have a packed #transthyretin #amyloidosis session with exciting talks and an expert panel of discussants and moderators. Join us https://t.co/NY1uaAUzn4 #CardioTwitter https://t.co/XeqQJeql7U

  • Mashup Score: 0
    Register | THT 2023 - 1 year(s) ago

    THT 2023 is the second year of the Technology and Heart Failure Therapeutics conference. Building on last year’s wildly successful inaugural THT conference, THT 2023 is an immersive, three-day experience in the latest innovations that practitioners can put into practice for treating heart failure. THT 2023 is an in-person-only meeting. No part of it will be livestreamed. The THT 2023 meeting is…

    Tweet Tweets with this article
    • Another hot topic debate at #THT23 you don’t want to miss How to tackle ischemic CAD in the setting of HF? Applying REVIVED BCIS2 @ericjvelazquez will argue pro-GDMT and @JWMoses will speak on when revascularization is appropriate Be in the room: https://t.co/U9btvSNQ5T https://t.co/ii5LOAiiya

  • Mashup Score: 4

    Discover cutting-edge #heartfailure research at #THT2023! Don’t miss late-breaking clinical science in Boston. https://tht2023.crfconnect.com/program-guide?s…

    Tweet Tweets with this article
    • Just back from #ACC23 but already looking forward to the LBCT coming up at #THT23. See you all in Boston for what will be a terrific conference! @manreetkanwar @AndrewJSauer @BurkhoffMd @Abraham_Jacob @NirUrielMD @preventfailure @AHajduczok @HFpEF https://t.co/kbgIGu0zYi

  • Mashup Score: 0
    Register | THT 2023 - 1 year(s) ago

    THT 2023 is the second year of the Technology and Heart Failure Therapeutics conference. Building on last year’s wildly successful inaugural THT conference, THT 2023 is an immersive, three-day experience in the latest innovations that practitioners can put into practice for treating heart failure. THT 2023 is an in-person-only meeting. No part of it will be livestreamed. The THT 2023 meeting is…

    Tweet Tweets with this article
    • Don’t miss this engaging debate at #THT23 @crfheart on therapeutic options for patients with severe MR and LV dysfunction, @gtsayer will give the Pro-OHT/VAD and Dr. Mark Reisman will counter on WHY TEER can be an option register: https://t.co/U9btvSNQ5T 2 weeks away.. https://t.co/2hadzJkktO